Lutetium ethylenediaminetetramethylene phosphonate is a radiopharmaceutical commonly used for its analgesic effect in patients with bone cancer, and relaxin inhibits the Notch‐1 pathway in OS cells through the Notch‐1 pathway.242. This evidence concerns the gene NOTCH1 and bone neoplasm.